LD-2 disclosure · 3rd Quarter - Amendment
ILLUMINA, INC.
via ILLUMINA, INC.
Client
- Name
- ILLUMINA, INC.
- Location
- California · United States of America
Registrant
- Firm
- ILLUMINA, INC.
- Description
- ​Sequencing and Array-based Solutions for Genetic Research, Clinical and Applied Markets.
- Location
- SAN DIEGO, California, United States of America
Lobbying activities
3 issuesHealth Issues
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
LobbyistsNICOLAS MAGALLANES
TargetedSENATE · HOUSE OF REPRESENTATIVES
Defense
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
LobbyistsNICOLAS MAGALLANES
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
LobbyistsNICOLAS MAGALLANES
TargetedSENATE · HOUSE OF REPRESENTATIVES